Find trial navigators, coordinators, and other support resources.
Your primary care doctor or even your specialist may not know about all the trials available for your condition. This isn't because they don't care; it's because trials are registered across thousands of sites nationally and internationally. Your local doctor likely doesn't have comprehensive visibility into trials happening at academic medical centers across the country or internationally. Additionally, some specialists at those centers may be leading trials that your local doctor simply isn't aware of.
You can absolutely discuss trials with your doctor, and it is a good idea once you have found one that interests you. To find trials in the first place, however, you will often need to reach out to other resources.
Many rare disease patient advocacy groups have trial navigators on staff. These are people whose job is to help patients find and understand trials. Organizations like NORD, NIH GARD, and disease-specific foundations maintain lists of trials and often connect patients with researchers. These organizations also provide medical summaries of your condition, which can help you prepare for conversations with trial coordinators.
This is one of the most valuable resources you have. Advocacy organizations understand your disease, know the researchers, and often have relationships with trial sites.
Major academic medical centers often have clinical research departments. The coordinators there match patients to trials. You can call the clinical research office at a major hospital or cancer center and tell them about your condition. They may have trials open or know of ones nearby.
You don't need to be a current patient at that hospital to reach out. Many research coordinators take calls from people looking to enroll.
Every trial listed on public registries includes the name and phone number of a site contact. Call them directly. Research sites expect patient inquiries and can answer preliminary questions about eligibility and the enrollment process.
This contact information is published specifically so patients can reach out. You don't need to go through your doctor or any intermediary to make that first call.
If your condition is genetic or if gene therapy trials might be relevant, a genetic counselor can help you understand eligibility and prepare for enrollment. Many hospitals have genetic counselors on staff, and you can often access them via telemedicine.
They also help you interpret genetic test results, which is often necessary before trial enrollment.
Trial matching services bridge the gap between ClinicalTrials.gov's raw data and what patients actually need to know. The best ones translate eligibility criteria into plain language, filter trials by location and recruiting status, and surface the contact information you need to reach out directly.
Trial Friend is built for rare disease patients specifically and applies that translation layer across every disease in the rare-disease space. Other services include the NIH-funded Antidote.me, BreastCancerTrials.org for that condition specifically, MD Anderson's clinical trial finder for cancer, and disease-specific matching services run by individual advocacy organizations.
Patient navigators (sometimes called patient liaisons or research advocates) are real people who do this matching work for you. NORD's Patient Navigator Program connects rare disease patients with case managers who help locate trials, work through insurance issues, and prepare for enrollment conversations. The Cancer Support Community, the Patient Advocate Foundation, and most disease-specific foundations also have navigator programs. Using a navigator is free.
The federal government runs several patient-facing programs that are underused for trial discovery. The NIH Clinical Center in Bethesda, Maryland is the world's largest research hospital and runs trials for many rare diseases at no cost to participants, with travel covered. You can reach the Clinical Center's patient recruitment office directly at 1-800-411-1222 or through their patient referral website.
The NIH Genetic and Rare Diseases Information Center (GARD) maintains a searchable database of rare diseases with linked trials, patient organizations, and educational materials. GARD's information specialists answer specific questions by phone or email at no cost. The National Center for Advancing Translational Sciences (NCATS) runs the Rare Diseases Clinical Research Network, which spans more than 20 consortia studying specific rare disease groups, each with its own trial pipeline and patient registry.
For families who can travel, the NIH's Undiagnosed Diseases Network (UDN) accepts applications from patients whose conditions have eluded diagnosis. Acceptance into the UDN is free and includes comprehensive evaluation that often leads to either a diagnosis or to identification of a relevant trial.
Patient registries collect long-term data on people living with a specific condition, and they double as a recruitment pipeline for clinical trials. Researchers contact registries when designing new trials and when an existing trial has open slots, so being in your disease's registry keeps you visible to the next study before it's even publicly listed.
The Coordination of Rare Diseases at Sanford (CoRDS) registry covers more than 1,000 rare conditions in a single platform and is one of the most important registries to know about. Many disease-specific organizations run their own registries (the Cystic Fibrosis Foundation Patient Registry, the Sickle Cell Disease Implementation Consortium, the Hemophilia Federation of America, and many others). Joining a registry typically takes 30 to 60 minutes online and updates annually.
Online patient communities also drive trial awareness. Reddit communities, Facebook groups, and disease-specific forums often hear about new trials before clinicians do, because patients in those communities are watching for relevant news. Communities are not a substitute for verified information, but they are good early-warning systems for trials that haven't yet hit your specialist's radar.
Drug manufacturers run patient-facing offices that most patients never call. The Medical Affairs department at a pharma company answers physician and patient inquiries about their drugs, including investigational programs. If a company has a drug in development for your condition, their Medical Affairs team can tell you which trials are open, which sites are enrolling, and whether expanded access or compassionate use programs exist.
Patient services groups (sometimes called patient support, patient advocacy, or patient experience) handle case management for patients on approved drugs and often help with trial enrollment too. Vertex's Patient Connect, Bluebird's BluebirdConnect, Sarepta's SareptAssist, and Biohaven's patient support are examples. They typically offer free phone support, financial assistance navigation, and trial information for the company's pipeline.
Reaching a manufacturer's medical affairs or patient services line is straightforward: their main website typically has a patient-facing contact page, or you can ask the trial coordinator to facilitate the connection. These conversations are protected by federal regulations against off-label promotion, so the information you receive will be strictly factual rather than promotional.
For rare diseases specifically, the most efficient first contact is your disease's main patient advocacy organization. They typically have a trial navigator on staff, an updated list of active trials, and contacts at the academic centers running them. NORD's Patient Navigator Program is a good starting point if your disease doesn't have its own dedicated organization. Trial Friend's disease pages also list active trials with direct contact links.
No. You can contact a trial coordinator directly without a referral, and most coordinators expect calls from patients and families. The contact information published on ClinicalTrials.gov is specifically for patient inquiries. Your doctor will need to be looped in later for records sharing, but the first call is yours to make.
The principal investigator (PI) is the lead physician or researcher responsible for the trial scientifically. The study nurse manages day-to-day patient care during trial visits. The research coordinator handles administration, scheduling, eligibility screening, and most of the patient-facing communication. For most patient questions, the research coordinator is your primary contact; the PI gets involved for medical decisions and adverse events.
Yes, especially for genetic rare diseases and gene therapy trials. Genetic counselors at major academic centers know which trials require specific gene variants and which centers are running them. They also help interpret existing genetic test reports for trial eligibility purposes. Telehealth genetic counseling has expanded significantly and is often covered by insurance under medical-necessity criteria.
A patient registry collects long-term natural-history data on people living with a specific condition. Registries are used to design future clinical trials and to recruit patients when a new study opens. Joining a registry takes 30 to 60 minutes online and keeps you visible to researchers when relevant trials launch, often before those trials are publicly listed. Many rare disease patients first hear about trials they qualify for through their registry rather than through their physician.
Yes. Pharmaceutical company Medical Affairs and Patient Services teams take calls from patients and families. They can confirm which trials are open, which sites are enrolling, and whether expanded access or compassionate use programs exist for their drug. Federal regulations prohibit promotional language in these conversations, so the information you receive will be factual. Find the contact through the manufacturer's main website or ask a trial coordinator to facilitate the connection.